Friday, March 9, 2012

Inflammatory Bowel Disease DBP

Ashwin et al.,

Discussed policy and security details about joining an existing registry who have prospectively consented to an identified study with a data mart of IBD patients that contains those very same patients.

Reviewed NLP performance with ~800 gold-standard annotated (399 Crohn's and 378 Ulcerative Colitis) and 201 controls gold-standard annotated (each with approximately 8 years follow-up).

No comments: